検索結果

OTC Products, etc. | Products | SENJU Pharmaceutical

Inquiries are not accepted in a language other than Japanese in principle. Please kindly understand the situation that the inquiries by telephone must use Japanese only. Translated from the Japanese p...

maged, leading to progressive visual field loss, and if left untreated, can result in blindness. In Japan, glaucoma is reported to be the leading cause of visual impairment (including reduced vision a...

このサイトについて | 千寿製薬株式会社

refox：最新 Macintoshをご利用の場合 OS Mac OS X 10.13以降 ブラウザ Safari：最新 ※上記以外のOS、ブラウザをご使用の場合、正しく表示されない場合があります。 JavaScriptについて 当サイトの一部のコンテンツにおいては、JavaScriptを使用しております。ブラウザの設定でJavaScriptを無効にされている場合、正しく表示されない場合がございま...

maged, leading to progressive visual field loss, and if left untreated, can result in blindness. In Japan, glaucoma is reported to be the leading cause of visual impairment (including reduced vision a...

ion of Marketing Approval for “ Mytear LUMIFY” Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida) today announces that it has received approval for the marketin...